Over the past year, we have advanced our 3D tissue imaging into an open-architecture AI platform designed to accelerate drug development for inflammatory skin diseases.
The platform translates complex tissue data into quantitative, mechanistic insight that supports decision-making across research and development.
If you are attending SID, reserve a personal demo to explore upcoming capabilities.

Use the link or scan the code to book your session.